Cargando…
Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009)
BACKGROUND: A major concern with using antiretroviral (ARV)-based products for HIV prevention is the potential spread of drug resistance, particularly from individuals who are HIV-infected but unaware of their status. Limited data exist on the prevalence of HIV infection or drug resistance among pot...
Autores principales: | Parikh, Urvi M., Kiepiela, Photini, Ganesh, Shayhana, Gomez, Kailazarid, Horn, Stephanie, Eskay, Krista, Kelly, Cliff, Mensch, Barbara, Gorbach, Pamina, Soto-Torres, Lydia, Ramjee, Gita, Mellors, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621859/ https://www.ncbi.nlm.nih.gov/pubmed/23585827 http://dx.doi.org/10.1371/journal.pone.0059787 |
Ejemplares similares
-
Correction: Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009)
por: Parikh, Urvi M., et al.
Publicado: (2014) -
PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa
por: Skhosana, Mandisa, et al.
Publicado: (2016) -
Perceptions of vaginal microbicides as an HIV prevention method among health care providers in KwaZulu-Natal, South Africa
por: Ramjee, Gita, et al.
Publicado: (2007) -
Spatial variations in STIs among women enrolled in HIV prevention clinical trials in Durban, KwaZulu-Natal, South Africa
por: Dassaye, Reshmi, et al.
Publicado: (2023) -
Gender, Migration and HIV in Rural KwaZulu-Natal, South Africa
por: Camlin, Carol S., et al.
Publicado: (2010)